Cargando…
A New Platinum-Based Prodrug Candidate for Chemotherapy and Its Synergistic Effect With Hadrontherapy: Novel Strategy to Treat Glioblastoma
Glioblastoma (GBM) is the most common tumor of the central nervous system. Current therapies, often associated with severe side effects, are inefficacious to contrast the GBM relapsing forms. In trying to overcome these drawbacks, (OC-6-44)-acetatodiamminedichlorido(2-(2-propynyl)octanoato)platinum(...
Autores principales: | Ferrari, Beatrice, Roda, Elisa, Priori, Erica Cecilia, De Luca, Fabrizio, Facoetti, Angelica, Ravera, Mauro, Brandalise, Federico, Locatelli, Carlo Alessandro, Rossi, Paola, Bottone, Maria Grazia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8019820/ https://www.ncbi.nlm.nih.gov/pubmed/33828444 http://dx.doi.org/10.3389/fnins.2021.589906 |
Ejemplares similares
-
Deeper and Deeper on the Role of BK and Kir4.1 Channels in Glioblastoma Invasiveness: A Novel Summative Mechanism?
por: Brandalise, Federico, et al.
Publicado: (2020) -
Hadrontherapy
por: Amaldi, Ugo, et al.
Publicado: (1997) -
1st International Week on Hadrontherapy : Advances in Hadrontherapy
por: Amaldi, Ugo, et al.
Publicado: (1997) -
The National Centre for Oncological Hadrontherapy at Mirasole: hadrontherapy programme
por: Amaldi, Ugo
Publicado: (1997) -
Study on the activation of cell death mechanisms: in search of new therapeutic targets in glioblastoma multiforme
por: Gaiaschi, Ludovica, et al.
Publicado: (2023)